ArticleFrontiers in public health2026
Cohort profile: Guangdong Pharmaceutical University Occupational Health Cohort in Xishan Coal Electricity Group (GDPU-OHC).
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Non-communicable diseases (NCDs) are an important public health concern among coal miners, who may experience occupational hazards, demanding working conditions, and unhealthy lifestyles. The Guangdong Pharmaceutical University Occupational Health Cohort in Xishan Coal Electricity Group (GDPU-OHC) is an ambispective occupational cohort established to characterize NCD burden, identify high-risk occupational groups, support future longitudinal analyses, and inform occupational health management in China. Participants: GDPU-OHC was conducted in Shanxi Province, China, with a retrospective component covering 2009-2022 and a prospective component initiated in May 2023. Among 36,577 workers with routine health examination records in 2023, 25,597 eligible employees (median age: 41.00 years, IQR: 35.00-50.00; 89.19% male) were recruited into the prospective cohort. All baseline participants were asked to provide fasting blood and urine samples. The main cohort is scheduled for follow-up every 3-5 years. Planned sub-studies include occupational protection improvement ( Findings to date: Among baseline participants, the crude prevalence of obesity, hypertension, type 2 diabetes, hyperuricemia, and hyperlipidemia was 22.64, 23.18, 13.89, 27.87, and 47.93%, respectively. Occupational hazards, including dust, noise, toxic gasses, and shift work, and lifestyle factors, including high oil/salt intake, smoking, and alcohol consumption, were common in this cohort and will serve as key exposures for future longitudinal analyses of NCD risks. These findings are descriptive; temporal trends and exposure-outcome associations were not assessed in the present cohort profile. Future plans: The GDPU-OHC will continue prospective follow-up to capture long-term NCD outcomes and repeated occupational health information. Future studies will evaluate longitudinal associations between occupational/lifestyle exposures and NCD risks, develop planned sub-studies, and conduct mechanistic analyses involving oxidative stress, inflammatory markers, metabolomics, and gene-environment interactions. Study findings will be disseminated through serial publications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.